Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The histamine system is a multifaceted physiological network mediated by the biogenic amine histamine, which acts as a local hormone and neurotransmitter (StatPearls, 2023). It exerts its effects through four distinct G protein-coupled receptors, designated H1 through H4, each with specific tissue distributions and signaling pathways (IUPHAR/BPS, 2024). The H1 receptor is primarily involved in allergic responses, smooth muscle contraction, and the regulation of wakefulness in the brain (PubMed, 2021). The H2 receptor is a key regulator of gastric acid secretion by parietal cells in the stomach and also influences cardiac contractility (NIH, 2022). H3 receptors function as presynaptic autoreceptors and heteroreceptors in the central nervous system, modulating the release of histamine and other neurotransmitters like acetylcholine and dopamine (Wikipedia, 2024). H4 receptors are predominantly expressed on hematopoietic cells, such as mast cells and eosinophils, where they mediate chemotaxis and inflammatory responses (UniProt, 2024). Pharmacological targeting of this system is highly diverse, including H1-antihistamines for allergies, H2-receptor antagonists for peptic ulcers, and H3-receptor inverse agonists for narcolepsy (PubChem, 2024). Beyond receptors, the system includes enzymes like histidine decarboxylase for synthesis and histamine N-methyltransferase for degradation, which are also potential therapeutic targets (PubMed, 2020). Dysregulation of the histamine system is implicated in a wide range of conditions, from common hay fever to complex neurological and gastrointestinal disorders (StatPearls, 2023).
Modulation of the histamine system occurs through antagonism or inverse agonism of H1, H2, H3, and H4 receptors, or through the inhibition of histamine synthesis via histidine decarboxylase (StatPearls, 2023; IUPHAR/BPS, 2024).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histamine system.